About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,766 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,766 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1101-1120 of 4,766 trials

CompletedSorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsThe purpose of this research study is to find out more about the combination of RAD001 and sorafenib such as the safest dose to use, the side effects it may cause, and if the drug…NCT00942682·Boston, Massachusetts RecruitingClinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid TumorsThis is a phase I clinical study to evaluate the safety and tolerability of CAR-T in patients with CEA-positive advanced/metastatic solid tumors, and to obtain the maximum…NCT06010862·Nanchang, Jiangxi CompletedBortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsRATIONALE: Bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00622674·Minneapolis, Minnesota RecruitingAdministering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing CancersBackground: In a new cancer therapy, researchers take a person s blood, select a certain white blood cell to grow in the lab, and then change the genes of these cells using a…NCT02830724·Bethesda, Maryland

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

TerminatedVaccine Therapy in Treating Patients With Cancer of the Gastrointestinal TractRATIONALE: Vaccines may make the body build an immune response to kill tumor cells.NCT00012246·Galveston, Texas

CompletedVaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic CancerRATIONALE: Vaccines made from donated tumor cells treated with interferon alfa may make the body build an immune response to and kill pancreatic tumor cells.NCT00002773·Los Angeles, California

CompletedEfficacy of the Transversus Abdominis Plane Block on Analgesia After Cephalic Duodeno-pancreatectomyPancreatic duodenectomy is one of the treatments offered to patients with neoplastic disease of the pancreas.NCT05546970·Strasbourg

CompletedSafety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard CareBVAC-B is immunotherapeutic vaccine using B-Cell and Monocytes as antigen presenting cell.NCT03425773·Seoul, Seodaemun-gu

TerminatedBlue and Amber Light Exposure in Patients With Rectal and Pancreatic CancerThis study will evaluate light therapy used in combination with standard therapies for pancreatic and rectal cancer.NCT06164691·Pittsburgh, Pennsylvania

CompletedInvestigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic CancerInvestigating the Optimal Duration of Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer to Determine the True Surgical Indication.NCT06809374

CompletedIrinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic CancerTo evaluate efficacy and safety of irinotecan hydrochloride liposome in combination with 5-FU/LV as second-line treatment for locally advanced or metastatic pancreatic cancer…NCT05074589·Nanjing, Jiangsu

RecruitingGLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular CancerThere is a growing number of patients diagnosed with gastrointestinal cancers who are also simultaneously being treated with GLP-1 Receptor Agonists (RA)s.NCT07627191·Tucson, Arizona

UnknownAMT-151 in Patients With Selected Advanced Solid TumoursThis first-in-human study will evaluate the Maximum Tolerated Dose (MTD) / the Recommended Phase 2 Dose (RP2D), safety, tolerability, anti-tumor activity, pharmacokinetics…NCT05498597·Sydney, New South Wales and 8 others

CompletedVaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerRATIONALE: Vaccines made from gene-modified tumor cells may help the body build an immune response to kill tumor cells.NCT00305760·Baltimore, Maryland

RecruitingGenetic Bases of Neuroendocrine Neoplasms in Mexican PatientsNeuroendocrine neoplasms (NENs) are a heterogeneous group of lesions derived from cells with the ability to produce hormones that may arise from multiple different organs.NCT06523582·Mexico City, Mexico City and 2 others

RecruitingEvaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE StudyThis clinical trial evaluates the safety and effectiveness of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for the management of patients with pancreatic tumors…NCT05961982·Columbus, Ohio

CompletedThe Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary ZoneThe Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary ZoneNCT04763642·Krasnodar, Krasnodarskiy Kray

Not yet recruitingConventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head CancersThe goal of this clinical trial is to learn if traditional pancreaticoduodenectomy (PD) combined with TRIANGLE (extended PD surgery) can increase disease-free survival (DFS) in…NCT06703905

CompletedPaclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic CancerPhase II trial to study the effectiveness of combining paclitaxel and bryostatin-1 in treating patients who have locally advanced unresectable or metastatic pancreatic cancer.NCT00031694·The Bronx, New York

CompletedSafety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC)10 Patients with Locally Advanced Pancreatic Cancer, no further responsive to neoadjuvant treatments but with a Stage-III disease will be submitted to imILT (Immunostimulating…NCT02702986·Verona

PreviousPage 56 of 239Next